MRes in Translational Medicine
Translational Medicine allows experimental findings in the research laboratory to be converted into real benefit for the health and well-being of the patient, through the development of new innovative diagnostic tools and therapeutic approaches.
Duration: 1 year Full-Time or 2-3 years Part-Time
Closing Date: 30 June 2016 (Late applications may be considered if places are available)
Please Note - The MRes in Translational Medicine is currently being updated for September 2016 starters. This means that module and programme content may change from that listed above/below.
The Masters by Research (MRes) in Translational Medicine is an innovative programme which provides students with a research-intensive training experience in either the Centre for Cancer Research and Cell Biology (CCRCB) or the Centre for Experimental Medicine (CEM) which both boast state-of-the-art laboratory facilities.
The main objective of the MRes Programme in Translational Medicine is to provide high quality candidates with the research rigour, innovation culture and the leadership skills to be at the forefront of this translational revolution. Students will receive expert training in all aspects of translational medicine including how new experimental findings are translated into treatments for patients; the experimental steps in the process, the development of innovative solutions, business, management and leadership skills and an appreciation of marketing and financial aspects of translational medicine through interaction with business leaders and scientists from Biotech and Pharma.
QUB has an international reputation in translational medicine, achieved through the recognised metrics of high impact peer review publications, significant international research funding, the generation of exploitable novel intellectual property and the establishment of successful spin-out biotech companies. This ethos of innovation was recently recognised with the award of the Times Higher Education Entrepreneurial University of the Year.
There are three streams within the MRes Programme: Precision Cancer Medicine; Cardiovascular Medicine and Infection, Inflammation and Immunity. Students enter one of the three streams based on their choice of research project and will be based in one of the Research Centres.
The Precision Cancer Medicine Stream provides students with the opportunity to specialise in a discipline that is fast becoming the cornerstone of modern cancer prevention and control. It is also an entry point to an exciting new CCRCB – National Cancer Institute USA (CCRCB-NCI) Doctoral Training Programme (DTP) in Precision Cancer Medicine
The Diabetes and Cardiovascular Disease Stream aims to provide students with an advanced understanding of cardiovascular pathobiology in diabetes as the basis for exploring state-of-the-art translational approaches which underpin the development of novel diagnostic, prognostic and therapeutic applications for the clinical management of the devastating cardiovascular complications frequently associated with this disease.
The Infection, Inflammation and Immunity Stream instils in students a greater understanding of these common disease processes and how this increased knowledge can underpin new approaches in infectious disease, respiratory disease and diseases with an (auto) immune component
In addition to a strong research focus, the MRes in Translational Medicine also emphasises the importance of innovation and entrepreneurship, through strong partnerships with the biotech and pharmaceutical industries, the Queen’s Management School and the William J Clinton Leadership Institute at Queen’s. Students undertake a module which expose them to the key technical, business and entrepreneurial principles and skills that will make them competitive in their future careers.
Two modules are taken in the 1st semester. The Research Translation: From Concept to Commercialisation Module (which will run over the 1st and 2nd Semesters) is a core module which cover the entire continuum from research discovery to clinical/commercial application. This Module (which will be delivered in collaboration with Queens’s Management School) will include talks from experts in the biotech/pharma/devices sector on the key requirements to translate discovery science into clinical entities (diagnostics, devices, drugs) that can deliver clinical, economic and societal benefit.
The 2nd Core Module is Genomics and Human Disease. This Module introduces the student to the molecular and cellular principles that underpin human disease processes. A series of lectures, tutorials and workshops will underpin this Module and inform students on the latest developments in the molecular and cellular basis of disease, highlighting the role of genes and genetic mutation in disease development.
In the 2nd Semester, students continue their research project and also undertake two advanced modules which are Research Centre specific. So, if you chose to do a project in Precision Cancer Medicine Stream, two cancer focussed modules (Cancer Biology and Translational Cancer Medicine) will be delivered by staff from CCRCB. Similarly, if you chose the Cardiovascular Medicine Stream, your project is based in CEM, and your two discipline-specific modules will be Cardiovascular Biology and Disease and Translational Cardiovascular Medicine while for a student who undertakes the Infection, Inflammation and Immunity Stream will be based in Cii and will undertake the Infection and Immunity and the Inflammation: From Cell to Clinic Modules.
As well as lectures and workshops, students will also have the opportunity to both hear and talk to other researchers both from the UK and around the world at the weekly research seminars which are part of the course requirements. In addition, we will be organising a series of career seminars during the year as part of your continuing professional development.
A minimum 2:1 honours degree (or equivalent) in a relevant biological subject is required. Evidence of equivalent professional qualifications (MBBS, BDS or BVSc) or relevant experience will be considered on an individual basis. Applicants may be required to undertake an interview.
- an IELTS score of 6.5 with not less than 6.0 in each of the four components: Elements of Listening, Reading, Speaking and Writing and achieved within the last 2 years;
- a TOEFL score of 90+ (internet based test), taken within the last 2 years, with minimum component scores of Listening – 20, Reading – 19, Speaking – 21 and Writing – 20;
- a valid certificate of Proficiency in English grade A or B;
- a valid certificate of Advanced English grade A; or
- a first or upper class honours degree from a university in the UK, Republic of Ireland or other suitability quality assured location in a country deemed by the UK Border Agency to be a majority English speaking.
For further information on Tuition Fees and payment options please refer to the University's webpages for Tuition Fees.
Sources of Funding
Napp Pharmaceuticals Limited Scholarship for the MRes in Translational Medicine (Asthma or COPD)
Two scholarships of £4,005 will be awarded to two individuals to undertake the Masters degree ‘MRes in Translational Medicine’. This includes an extensive project and Dissertation in asthma or COPD research in the Centre for Experimental Medicine.
This Award is open to all applicants and will be conditional upon a minimum 2.1 honours degree in a relevant biological subject. For further information, please click here.
Closing date 29 April 2016
Mundipharma Ireland Educational Grant for the MRes in Translational Medicine (Asthma or COPD)
One scholarship of £4,005 will be awarded to an individual to undertake the Masters degree ‘MRes in Translational Medicine’. This includes an extensive project and Dissertation in asthma or COPD research in the Centre for Experimental Medicine.
This Award is open to applicants from the Republic of Ireland and will be conditional upon a minimum 2.1 honours degree in a relevant biological subject. For further information, please click here.
Closing date 29 April 2016
Queen’s University will be offering a number of exciting scholarships to talented international students. The latest information will be available on this website early in 2015. Please refer to the University’ International Scholarship webpages for further details.
Please refer to the US Federal loan webpages to find out if you are eligible.
Other Sources of Funding
For information on other potential sources of funding please refer to the University’s Postgraduate Funding webpages .
How to Apply
Candidates should make applications through the Universities Online Admissions portal.
Guidance is available on the University’s Prospective Student pages.
When applying please choose 'Medicine’ as your subject area/School.
For further advice on the application process at QUB please contact:
Admissions and Access Service
Queen’s University Belfast
Tel: +44 (0)28 9097 5081
Professor Mark Lawler
Centre for Cancer Research and Cell Biology
Telephone: +00 (44) 028 9097 2931
Further Information for International Students
The University welcomes International Students each year. Candidates may find the University’s International Student Support Office webpages useful for finding out more about living and studying in Belfast.
Once you have applied and accepted your place at the University you mayfind the University’s Admissions webpage for new students webpages of interest. These webpages contain useful information which will assist you in making the necessary arrangements prior to coming to Belfast to study.
The MRes in Translational Medicine will equip students with the appropriate skills to be at the forefront of the translational medicine revolution in academia, in the hospital environment and in the biotech/pharmaceutical industries. An unrivalled exposure to the financial, management and entrepreneurial aspects of translational research will expedite their ability to exploit commercial opportunities in these innovation-rich sectors. It will also provide graduates with the skill set and academic rigor necessary to progress to a PhD in a biomedical discipline.
“The MRes course offers a solid foundation in translational research which in my experience is equally applicable to academic and industrial career paths.”
Professor Richard Kennedy MB, BCh, BAO, BSc, PhD, FRCP
Centre for Cancer Research and Cell Biology.
Medical Director, Almac Diagnostics
McClay Professor and Reader in Experimental Cancer Medicine,
Intercalated applications for starting in September 2015 are now closed. Intercalated applications for 2016/17 will open in Autumn 2015
This Masters can be taken by students wishing to intercalate following the third year medical or dental examinations. The School are offering up to 10 competitive Intercalated Scholarships to complete a Masters programme. The Scholarships, up to the value of £6500.00 each and will cover the Tuition Fees and a Bursary.
Terms of Intercalated Scholarships (including eligibility):
- Students must be a registered medical or dental students at Queen’s University.
- Must have successfully completed, or be due to complete, third year medical or dental examinations on the first attempt with an overall classification of a 2.1
- Must have applied online to undertake the Bioinformatics & Computational Genomics, Clinical Anatomy, MPH or the MRes as intercalated degrees by 31 January 2015.
- The scholarships will be competitive and will be awarded on the basis of academic rankings used to calculate distinctions at the end of year two.
- Students should apply via the Queen’s on–line portal https://dap.qub.ac.uk/portal/user/u_login.php
- You will automatically be considered for one of the Intercalated Scholarships using the above criteria.
APPLY ONLINE : https://dap.qub.ac.uk/portal/user/u_login.php
Please click here for further information on Intercalated degrees.